Communications, Planning and Administration The Communication, Planning and Administration Core (Core 6) will organize and fund the distributed research that takes place in the SPORE. This includes responsibility for both federally funded research, and the administration of institutional funds made available to us by the Dana-Farber Cancer Institute. This Core will organize the evaluation of SPORE scientific projects and core resources by 1) constituting an External Advisory Board, 2) organizing meetings of the Internal Advisory Board, and 3) reporting to the Steering Committee of the Dana-Farber/Harvard Cancer Center (DF/HCC) Breast Program. We will foster communication by holding regular research-in-progress meetings, annual retreats, attendance at Workshops and Roundtables, and by planning seminars and symposia. The Core will continue to arrange the visits of outside scientists and clinical leaders to Boston for the purpose of meeting with SPORE investigators and providing us with reports of their research. The Core will provide integration of the SPORE into the DF/HCC by reporting to and participating in Cancer Center committees, using Center Core Resources, and providing valuable SPORE resources to DF/HCC members. Planning and policy will be provided by the Core Coordinating Committee for use of shared resources in the SPORE. This Core will facilitate and promote the activities of an Advocacy Committee, involve advocates in planning activities of the SPORE, and report to the Committee at their request. Core 6 provides fiscal oversight for the entire SPORE including subcontracting to participating institutions, reporting to the NCI, and insuring the rapid use of available funds to promote breast cancer research. The Core also will administer privately raised funds that are earmarked to support Core activities. The Core will also publicize our data sharing strategies and policies and continue to promote open sharing of scientific information.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA089393-10
Application #
7927075
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
10
Fiscal Year
2009
Total Cost
$162,177
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Kabraji, Sheheryar; Ni, Jing; Lin, Nancy U et al. (2018) Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain? Clin Cancer Res 24:1795-1804
Punglia, Rinaa S; Jiang, Wei; Lipsitz, Stuart R et al. (2018) Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery. Breast Cancer Res Treat 167:751-759
Liu, Hui; Murphy, Charles J; Karreth, Florian A et al. (2018) Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer. Cancer Discov 8:354-369
Asdourian, Maria S; Swaroop, Meyha N; Sayegh, Hoda E et al. (2017) Association Between Precautionary Behaviors and Breast Cancer-Related Lymphedema in Patients Undergoing Bilateral Surgery. J Clin Oncol 35:3934-3941
Sun, Fangdi; Skolny, Melissa N; Swaroop, Meyha N et al. (2016) The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema. Breast Cancer Res Treat 157:229-240
Ferguson, Chantal M; Swaroop, Meyha N; Horick, Nora et al. (2016) Impact of Ipsilateral Blood Draws, Injections, Blood Pressure Measurements, and Air Travel on the Risk of Lymphedema for Patients Treated for Breast Cancer. J Clin Oncol 34:691-8
Miller, Cynthia L; Colwell, Amy S; Horick, Nora et al. (2016) Immediate Implant Reconstruction Is Associated With a Reduced Risk of Lymphedema Compared to Mastectomy Alone: A Prospective Cohort Study. Ann Surg 263:399-405
Sherr, Charles J; Beach, David; Shapiro, Geoffrey I (2016) Targeting CDK4 and CDK6: From Discovery to Therapy. Cancer Discov 6:353-67
Asdourian, Maria S; Skolny, Melissa N; Brunelle, Cheryl et al. (2016) Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis. Lancet Oncol 17:e392-405
Kochupurakkal, Bose S; Iglehart, J Dirk (2016) Identification of genes responsible for RelA-dependent proliferation arrest in human mammary epithelial cells conditionally expressing RelA. Genom Data 7:92-3

Showing the most recent 10 out of 291 publications